1081. Implementation of a Centralized Infectious Diseases Telehealth (IDt) Service for 16 Small Community Hospitals
Session: Poster Abstract Session: Clinical Practice Issues
Friday, October 6, 2017
Room: Poster Hall CD
Posters
  • ID Telehealth IDWeek2017_Poster_Vento_20SEP17.pdf (2.3 MB)
  • Background:

    The majority of U.S. small community hospitals (SCHs) lack access to infectious diseases (ID) subspecialists. Telehealth can extend ID expertise to such facilities. We describe lessons learned from implementing a new IDt program for 16 SCHs in the Intermountain Healthcare system in Utah and Idaho.

    Methods:

    From October 1, 2016 to April 30, 2017, we implemented an IDt service comprised of: a 24-hour ID physician advice line; an inpatient ID consult service that provided chart review and documentation (e-consults) and daytime telemedicine consultation (TC) using encrypted, HIPAA-compliant, synchronous, 2-way audio-video connection; and an ID pharmacist-led antibiotic stewardship program. The IDt service included a medical director, operations officer, ID pharmacist, analyst, and rotating ID physicians, and was implemented in a step-wise manner at 16 SCHs. IDt requests were received through a dedicated phone line with duplicate transcription to a monitored email inbox or generated from daily antibiotic stewardship rounds.

    Results:

    The physician advice line was operational for all 16 SCHs on October 1, 2016. 312 advice-only calls were fielded (92 per 1000 hospital-days covered) through April 30, 2017. Common infections requiring phone advice included: bloodstream (16%), genitourinary (13%), and musculoskeletal (12%). E-consult and TC services were operational at 11 SCHs by April 30, 2017 (hospital-days covered: 1074). The IDt service completed 104 eConsults, 163 TCs, and 1198 stewardship reviews. Mean time [minutes (range)] spent per case was 16 (5-30) for eConsults and 55 (30-120) for TCs [on-camera time: 25 (12-46)]. Common infections requiring e-consult or TC were: bloodstream (45%), musculoskeletal (16%), and skin/soft tissue (11%). 22 patients (14%) seen by TC were surveyed: 100% felt the service improved their care and was necessary at their SCH. 97% of surveyed SCH staff felt the IDt service improved patient care and 90% felt it was a necessary service (32% response from 98 providers, nurses, pharmacists).

    Conclusion:

    A new IDt service was well utilized and received by SCH staff and patients, with bloodstream infections being the most common reason for consultation. Future steps include evaluation of the IDt effect on clinical outcomes, financial metrics, and staff education on common ID conditions.

    Todd J. Vento, MD, MPH1, Stephanie S. Gelman, MD2, John J. Veillette, PharmD2, Mary A. Adams, RN, BSN2, Katherine A. Repko, RN, MSN2, Peter S. Jones, MSLS3, Brandon J. Webb, MD4, Kristin K. Dascomb, MD, PhD3, Bert K. Lopansri, MD, FIDSA3 and Edward A. Stenehjem, MD, MSc5, (1)Infectious Diseases/Clinical Epidemiology, Intermountain Healthcare, Sandy, UT, (2)Intermountain Medical Center, Murray, UT, (3)Clinical Epidemiology and Infectious Diseases, Intermountain Medical Center, Murray, UT, (4)Intermountain Medical Center and LDS Hospital, Murray, UT, (5)Division of Infectious Disease, Intermountain Medical Center, Murray, UT

    Disclosures:

    T. J. Vento, None

    S. S. Gelman, None

    J. J. Veillette, None

    M. A. Adams, None

    K. A. Repko, None

    P. S. Jones, None

    B. J. Webb, None

    K. K. Dascomb, None

    B. K. Lopansri, None

    E. A. Stenehjem, None

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.